Inhibition of lectin-like oxidized low-density lipoprotein receptor 1 protects against plasma/hypoxia-mediated trophoblast dysfunction associated with preeclampsia

Gynecologic and Obstetric Investigation

Volumn 79, Issue 2, 2015, Pages 90-96

  Zhang, Yan ^a   Ye, Yuanhua ^a   Wang, Yufang ^a   Chen, Weiping ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

LOX 1; Placenta growth factor; Preeclampsia; sFlt 1; Trophoblast

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PLACENTAL GROWTH FACTOR; FLT1 PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN; OLR1 PROTEIN, HUMAN; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACENTA PROTEIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CELL CULTURE; CONTROLLED STUDY; CYTOTROPHOBLAST; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; HYPOXIA; MAJOR CLINICAL STUDY; MATERNAL AGE; OXIDATIVE STRESS; PATHOGENESIS; PLACENTA; PLASMA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA; TROPHOBLAST; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BLOOD; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ADULT; FEMALE; HUMANS; LIPOPROTEINS, LDL; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; SCAVENGER RECEPTORS, CLASS E; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84924252837     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000370195     Document Type: Article

References (42)

1. Roberts JM, Pearson G, Cutler J, Lindheimer M: Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003; 41: 437-445.
2. Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet 2005; 365: 785-799.
3. Lindheimer MD, Umans JG: Explaining and predicting preeclampsia. N Engl J Med 2006; 355: 1056-1058.
4. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005; 308: 1592-1594.
5. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
6. Maynard SE, Venkatesha S, Thadhani R, Karumanchi SA: Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res 2005; 57: 1R-7R.
7. Wang A, Rana S, Karumanchi SA: Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 2009; 24: 147-158.
8. He X, He Y, Xi B, Zheng J, Zeng X, Cai Q, Ouyang Y, Wang C, Zhou X, Huang H, Deng W, Xin S, Huang Q, Liu H: LncRNAs expression in preeclampsia placenta reveals the potential role of LncRNAs contributing to preeclampsia pathogenesis. PLoS One 2013; 8:e81437.
9. Myatt L, Webster RP: Vascular biology of preeclampsia. J Thromb Haemost 2009; 7: 375-384.
10. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP: Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008; 294:H541-H550.
11. Uzun H, Benian A, Madazli R, Topçuo?lu MA, Aydin S, Albayrak M: Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol Obstet Invest 2005; 60: 195-200.
12. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T: An endothelial receptor for oxidized low-density lipoprotein. Nature 1997; 386: 73-77.
13. Reiss AB, Anwar K, Wirkowski P: Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review. Curr Med Chem 2009; 16: 2641-2652.
14. Mitra S, Goyal T, Mehta JL: Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther 2011; 25: 419-429.
15. Lee H, Park H, Kim YJ, Kim HJ, Ahn YM, Park B, Park JH, Lee BE: Expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in human preeclamptic placenta: possible implications in the process of trophoblast apoptosis. Placenta 2005; 26: 226-233.
16. Sankaralingam S, Xu Y, Sawamura T, Davidge ST: Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite. Hypertension 2009; 53: 270-277.
17. Morton JS, Abdalvand A, Jiang Y, Sawamura T, Uwiera RR, Davidge ST: Lectin-like oxidized low-density lipoprotein 1 receptor in a reduced uteroplacental perfusion pressure rat model of preeclampsia. Hypertension 2012; 59: 1014-1020.
18. Sankaralingam S, Xu H, Jiang Y, Sawamura T, Davidge ST: Evidence for increased methylglyoxal in the vasculature of women with preeclampsia: role in upregulation of LOX-1 and arginase. Hypertension 2009; 54: 897-904.
19. Inoue N, Okamura T, Kokubo Y, Fujita Y, Sato Y, Nakanishi M, Yanagida K, Kakino A, Iwamoto S, Watanabe M, Ogura S, Otsui K, Matsuda H, Uchida K, Yoshimoto R, Sawamura T: LOX index, a novel predictive biochemical marker for coronary heart disease and stroke. Clin Chem 2010; 56: 550-558.
20. Lu J, Mitra S, Wang X, Khaidakov M, Mehta JL: Oxidative stress and lectin-like ox-LDLreceptor LOX-1 in atherogenesis and tumorigenesis. Antioxid Redox Signal 2011; 15: 2301-2333.
21. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683.
22. Gobble RM, Groesch KA, Chang M, Torry RJ, Torry DS: Differential regulation of human PIGF gene expression in trophoblast and nontrophoblast cells by oxygen tension. Placenta 2009; 30: 869-875.
23. Livingston JC, Chin R, Haddad B, et al: Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 2000; 183: 1554-1557.
24. Song C, Xie S, Wang J, Lian J, Diao B, Tang Y: Association of angiotensinogen gene polymorphisms and angiogenic factors with preeclampsia in Chinese women. Gynecol Obstet Invest 2013; 76: 64-68.
25. Huang QT, Wang SS, Zhang M, Huang LP, Tian JW, Yu YH, Wang ZJ, Zhong M: Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia. Placenta 2013; 34: 949-952.
26. Huang QT, Zhang M, Zhong M, Yu YH, Liang WZ, Hang LL, Gao YF, Huang LP, Wang ZJ: Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia. Placenta 2013; 34: 1177-1182.
27. Balin M, Celik A, Kobat MA, Baydas A: Pregnancy followed by delivery may affect circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in women of reproductive age. Mediators Inflamm 2012; 2012: 837375.
28. Wang Y, Walsh SW: Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in preeclampsia. Placenta 2001; 22: 206-212.
29. Gu Y, Lewis DF, Wang Y: Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J Clin Endocrinol Metab 2008; 93: 260-266.
30. Qiu C, Phung TT, Vadachkoria S, Muy-Rivera M, Sanchez SE, Williams MA: Oxidized low-density lipoprotein (Oxidized LDL) and the risk of preeclampsia. Physiol Res 2006; 55: 491-500.
31. Schreurs MP, Hubel CA, Bernstein IM, Jeyabalan A, Cipolla MJ: Increased oxidized lowdensity lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1. FASEB J 2013; 27: 1254-1263.
32. Pecks U, Caspers R, Schiessl B, Bauerschlag D, Piroth D, Maass N, Rath W: The evaluation of the oxidative state of low-density lipoproteins in intrauterine growth restriction and preeclampsia. Hypertens Pregnancy 2012; 31: 156-165.
33. Chen M, Masaki T, Sawamura T: LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 2002; 95: 89-100.
34. Zhang Y, Ye YH, Peng W, Zhan Y: Correlation of oxidized low-density lipoprotein and lectin-like oxidized low-density lipoprotein receptor-1 with pre-eclampsia. Zhonghua Fu Chan Ke Za Zhi 2009; 44:94-98.
35. English FA, McCarthy FP, McSweeney CL, Quon AL, Morton JS, Sawamura T, Davidge ST, Kenny LC: Inhibition of lectin-like oxidized low-density lipoprotein-1 receptor protects against plasma-mediated vascular dysfunction associated with pre-eclampsia. Am J Hypertens 2013; 26: 279-286.
36. Pijnenborg R, Vercruysse L, Brosens I: Deep placentation. Best Pract Res Clin Obstet Gynaecol 2011; 25: 273-285.
37. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA: Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002; 9: 147-160.
38. Torry DS, Hinrichs M, Torry RJ: Determinants of placental vascularity. Am J Reprod Immunol 2004; 51: 257-268.
39. Ye YH, Liu L, Zhan Y, Peng W: Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta. Zhonghua Fu Chan Ke Za Zhi 2006; 41: 521-524.
40. Karumanchi SA, Bdolah Y: Hypoxia and sFlt-1 in preeclampsia: the 'chicken-and-egg' question. Endocrinology 2004; 145: 4835-4837.
41. Murphy SR, LaMarca BB, Parrish M, Cockrell K, Granger JP: Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-c. Am J Physiol Regul Integr Comp Physiol 2013; 304:R130-R135.
42. Laresgoiti-Servitje E, Gomez-Lopez N: The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms. Biol Reprod 2012; 87: 36.